Other information 8100 Annual Report 2010 Annual Report 2010 15 03 2011 14:29 Page 129 ort and Accounts 2010 Shire plc Annual Report and Accounts 2010 129 Cautionary statements Statements included herein that are not historical facts are forwardlooking statements.
Such forward-looking statements involve a number of risks and uncertainties, and are subject to change at any time.
In the event such risks or uncertainties materialize, Shires results could be materially adversely affected.
The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing, and commercialization of the Shires Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and or development: government regulation of Shires products: Shires ability to manufacture its products in sufficient quantities to meet demand: the impact of competitive therapies on Shires products: Shires ability to register, maintain, and enforce patents and other intellectual property rights relating to its products: Shires ability to obtain and maintain government and other third-party reimbursement for its products: and other risks and uncertainties detailed from time to time in Shires filings with the Securities and Exchange Commission.
